hims - AI Stock Analysis

Analysis generated December 8, 2025

Hims & Hers Health Inc. (HIMS) is a telehealth company providing a range of products and services for men's and women's wellness. The company offers a diverse portfolio including personal care, sexual health, mental health, primary care, and more. Leveraging a digital platform, Hims aims to make healthcare accessible and convenient, appealing particularly to a younger, tech-savvy demographic.

Fundamental Analysis

Hims reported a revenue of $599 million in the last quarter, marking a 9.94% increase from the previous quarter. Year-over-year, the revenue increased by an impressive 49.16%. These figures highlight strong growth in the company's topline, a very positive indicator.

However, the net income tells a different story. The last quarter's net income stood at $16 million, a drastic 62.89% decrease from the prior quarter and a 79.13% decrease year-over-year. This sharp decline could indicate increased costs or challenges in maintaining profitability, warranting caution.

EBITDA for the last quarter was $12 million, reflecting a 68.25% decrease compared to the previous quarter and a 55.87% decrease year-over-year. This EBITDA trend suggests operational inefficiencies, further confirmed by the falling net income.

The company’s current Price/Earnings (P/E) ratio stands at 73.96, a potentially high figure that may suggest overvaluation and attract a bearish sentiment from investors.

Moreover, recent insider selling of company stock adds to the bearish outlook, hinting that those closest to the company's operations might have concerns about future performance.

Technical Analysis

The current stock price is $39.20, representing a 4.46% decrease over the past month. Despite the short-term decline, the stock has appreciated by 20.13% over the past year. This mixed performance suggests uncertainty among investors.

The trend is classified as bearish. The current Simple Moving Average (SMA) for the last 10 days (SMA10) is 38.72, slightly declining from the previous SMA10 of 38.78. This reinforces the potential downward course in the near term.

The Relative Strength Index (RSI) stands at 25.6, signaling an oversold condition that may present a potential buying opportunity for contrarian investors.

Alternative Data Analysis

Job postings at Hims are down by 27%, with 91 open positions as of the most recent data. This could indicate a strategic move to reduce workforce expenses amidst financial concerns.

Employee sentiment is low with only 44% holding a positive outlook, and this sentiment has decreased by 10% in recent months. This negative trend within the workforce can eventually influence operational efficiency and morale.

Web and app traffic trends also pose concerns. Webpage visitors are estimated at 400,000, down by 17%, whereas mobile app downloads stand at 2,000 per day, which is down by 14%. These metrics suggest potential issues with customer acquisition and engagement.

On social media, Hims has 230,000 Instagram followers showing stability but no notable increase. However, their Twitter followers have increased by 9%, indicating some growing interest.

AltIndex’s AI score, which integrates various factors, rates Hims at 39, a clear sell signal suggesting potential further downside.

Conclusion

To sum up, while Hims shows excellent revenue growth and a promising long-term stock price increase, concerns arise from declining profitability, insider selling, and weakening technical and alternative data indicators. Although there might be a short-term buying opportunity based on the RSI, long-term investors should be cautious due to high P/E ratio and overall bearish signals. Careful monitoring and thorough assessment are recommended before making any investment decisions.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.